Affiliation:
1. Organ Transplantation Center, Sichuan Academy of Medical Science and Sichuan Provincial People’s Hospital, Chengdu, P.R. China
2. The East Ward, Sichuan Academy of Medical Science and Sichuan Provincial People’s Hospital, Chengdu, P.R. China
Abstract
Forkhead box K1 (FOXK1) is a member of the FOX transcription factor family and plays an important role in the development of several tumors. However, the role of FOXK1 in the progression of prostate cancer remains unknown. Thus, the objectives of this study were to detect the expression
of FOXK1 in prostate cancer and to examine its role in prostate cancer cells. We found that the expression of FOXK1 at both the mRNA and protein levels was significantly upregulated in human prostate cancer cell lines. In addition, the downregulation of FOXK1 obviously inhibited the cell proliferation
of prostate cancer cells in vitro and attenuated tumor growth in a xenograft model in vivo. Furthermore, knockdown of FOXK1 suppressed the migration and invasion of prostate cancer cells, and prevented the EMT phenotype through upregulating the expression of E-cadherin, as well as downregulating
the expression of N-cadherin in prostate cancer cells. Mechanistically, knockdown of FOXK1 efficiently downregulated the expression levels of β-catenin, c-myc, and cyclin D1 in PC-3 cells. Overall, our results demonstrated that knockdown of FOXK1 inhibited the proliferation and metastasis
of prostate cancer, at least in part, through suppressing the Wnt/β-catenin signaling pathway. Therefore, these results suggest that FOXK1 may be a potential therapeutic target for human prostate cancer.
Subject
Cancer Research,Oncology,General Medicine
Reference24 articles.
1. Cancer statistics, 2017;CA Cancer J Clin.,2017
2. Prostate cancer trends in Latvia during 1990–2012: Incidence, prevalence, mortality, and survival rates;Medicina,2014
3. Intraoperative radiotherapy for locally advanced prostate cancer: Treatment technique and ultrasound-based analysis of dose distribution;Anticancer Res.,2007
4. Advancing prostate cancer: Treatment options for the urologist;Urol Clin North Am.,2006
5. Long-term overall survival and metastasis-free survival for men with prostate-specific antigen-recurrent prostate cancer after prostatectomy: Analysis of the Center for Prostate Disease Research National Database;BJU Int.,2010
Cited by
34 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献